ResMed's Cloud Innovations Enhance Chronic Disease Management
San Diego, Friday, 28 February 2025.
ResMed is advancing digital health with cloud connectivity for improved management of chronic diseases like sleep apnea and COPD, aiming to transform out-of-hospital patient care.
Global Impact and Market Presence
ResMed has established itself as a significant force in digital health innovation, operating across more than 120 countries with a workforce of 5,001-10,000 employees [1]. The company’s impact is particularly notable in addressing sleep disorders, with their 2025 Global Sleep Survey revealing that 70% of working individuals have called in sick due to poor sleep, while 18% of couples resort to sleeping separately due to sleep-related issues [1]. The scope of the challenge is substantial, with approximately one billion people worldwide affected by clinically significant sleep apnea, yet 90-95% remain undiagnosed [1].
Technical Infrastructure and Innovation
The company’s Digital Health Platform, headquartered in Sydney, manages healthcare solutions across more than 140 countries [2]. ResMed’s engineering teams are actively developing sophisticated API tooling and infrastructure improvements, focusing on enhanced security measures and automated testing frameworks to ensure reliable service delivery [2]. This technical foundation supports their cloud-connected medical devices, which are specifically designed to transform care for individuals with sleep apnea, COPD, and other chronic conditions [4].
Financial Performance and Growth
ResMed’s innovative approach has translated into strong financial performance, with the company reporting $1.3 billion in quarterly revenue in Q2 2025, alongside a 29% year-over-year growth in earnings per share [1]. This growth is driven by increasing demand for their comprehensive suite of devices, masks, and software solutions. The company’s expansion is further evidenced by their robust hiring initiatives, with 485 active job openings as of February 28, 2025 [4].
Patient-Centered Solutions
The impact of ResMed’s solutions extends beyond clinical outcomes to address quality of life issues. Their comprehensive sleep care solutions, showcased at Medtrade 2025, demonstrate the company’s commitment to supporting patients throughout their therapy journeys [1]. The effectiveness of their approach is illustrated through patient testimonials, such as Dave Whelan’s experience with CPAP therapy, which led to immediate improvements in daily energy levels and overall well-being [1].